On Tuesday, the Centers for Medicare and Medicaid Services announced a proposed rule for coverage of obesity drugs in Medicare and Medicaid, starting in 2026.
After notice and comment rulemaking, the rule would need to be finalized under the Trump Administration. Comments must be submitted no later than January 27, 2025.
